BACKGROUND: Peripheral artery disease (PAD) screening may be performed to prevent
progression of PAD or future cardiovascular disease in general. Recommendations for PAD …

Peripheral arterial disease (PAD) is part of a global vascular problem of diffuse
atherosclerosis. PAD patients die mostly of cardiac and cerebrovascular-related events and …

Background Lower extremity peripheral artery disease is the third leading cause of
atherosclerotic cardiovascular morbidity, following coronary artery disease and stroke. This …

Lower extremity peripheral arterial disease (PAD) affects approximately 10% of the
American population, with 30% to 40% of these patients presenting with claudication …

Peripheral artery disease (PAD), secondary to atherosclerotic disease, is currently the
leading cause of morbidity and mortality in the western world. While PAD is common, it is …

Background Previous efforts to characterize the burden of peripheral artery disease (PAD)
have focused on national populations. A need for a more detailed analysis of how PAD …

This Consensus Conference has been supported by the Canadian Cardiovascular Society.
The process is dynamic, with intentional structure that requires peer review and feedback …

Background Peripheral arterial disease (PAD) is the third leading cause of atherosclerotic
vascular morbidity after coronary heart disease and stroke. Epidemiology data of PAD is …

Background Peripheral artery disease (PAD), the third leading cause of atherosclerotic
vascular morbidity, affects approximately 202 million people worldwide, among whom more …

The term peripheral arterial disease (PAD) is often used to describe atherosclerosis
involving the arteries supplying the lower extremities. Potentially modifiable factors that …